Columbia Interventional Cardiologists to lead the 36th TCT Conference in Washington, D.C., known globally as the foremost platform for progressing interventional cardiovascular medicine.
Columbia Cardiology has launched the Mitral & Tricuspid Center, dedicated to exploring the latest devices and treatments for patients with mitral and tricuspid valve disease.
Columbia cardiologists will lead at New York Valves 2024, a summit on structural heart disease innovations, from June 5-7, featuring Columbia faculty lectures and panels.
Kimberly's routine checkup led to a life-threatening pulmonary embolism crisis, highlighting the power of collaborative medical intervention for survival.
We spoke with Michael Collins, MD, about his work as a proceduralist in the Cath lab here at Columbia's Interventional Cardiovascular Care program - NewYork-Presbyterian Hospital.
Columbia pioneers transformative cardiovascular care, from TAVR durability to groundbreaking approaches for tricuspid valve and hypertension, reshaping the future of cardiology.
Dr. Sonal Pruthi, MBBS, discusses her pivotal role in advancing endovascular services at Columbia's Interventional Cardiovascular Care program and her contribution to its expansion in Goshen, NY.
